International Journal of Leprosy and other Mycobacterial Diseases

Volume: 65 - Edition: 2 - Apr/May/Jun - 1997
Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results
Ibrahima Mane¹; Jean-Louis Cartel²; Jacques-Henri Grosset³

Volume: 62 - Edition: 2 - Apr/May/Jun - 1994
Progress in the chemotherapy of leprosy*
Jacques-Henri Grosset

Volume: 61 - Edition: 2 - Apr/May/Jun - 1993
Tuberculosis in leprosy patients detected between 1902 and 1991 in French Polynesia
Philippe Glaziou¹; Jean-Louis Cartel²; Jean-Paul Moulia-Pelat³; Lam N'guyen Ngoc⁴; Suzanne Chanteau⁵; Régis Plichart⁶; Jacques-Henri Grosset⁷

Volume: 60 - Edition: 3 - Jul/Aug/Sep - 1992
Chemoprophylaxis of leprosy with a single dose of 25 mg per kg rifampin in the southern marquesas; results after four years
Jean-Louis Cartel¹; Suzanne Chanteau²; Jean-Paul Moulia-Pelat³; Régis Plichart⁴; Philippe Glaziou⁵; Jean-Paul Boutin⁶; Jean-Félix Roux⁷; Jacques-Henri Grosset⁸

Volume: 58 - Edition: 3 - Jul/Aug/Sep - 1990
Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands
Jean-Louis Cartel¹; Suzanne Chanteau²; Jean-Paul Boutin³; Regis Plichart⁴; Patrick Richez⁶; Jean-Felix Roux⁵; Jacques-Henri Grosset⁷